Regional Metabolic Changes in the Hippocampus and Posterior Cingulate Area Detected with 3-Tesla Magnetic Resonance Spectroscopy in Patients with Mild Cognitive Impairment and Alzheimer Disease

References

• Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hänninen T, Laakso MP, et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 2004; 25: 303–10
   PubMed Web of Science ®Google Scholar
• Jack CR, Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52: 1397–403
   PubMed Web of Science ®Google Scholar
• Vogt BA, Van Hoesen GW, Vogt LJ. Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer disease. Acta Neuropathol 1990; 80: 581–9
   Google Scholar
• Soher BJ, Doraiswamy PM, Charles HC. A review of 1H MR spectroscopic findings in Alzheimer's disease. Neuroimag Clin N Am 2005; 15: 847–52
   PubMed Web of Science ®Google Scholar
• Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, et al. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology 2002; 58: 928–35
   PubMed Web of Science ®Google Scholar
• Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, et al. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. Neurology 2003; 61: 358–64
   Google Scholar
• Kantarci K, Jack CRJ, Xu YC, Campeau NG, O'Brien PC, Smith GE, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease. A 1H MRS study. Neurology 2000; 55: 210–7
   PubMed Web of Science ®Google Scholar
• Chantal S, Braun CM, Bouchard RW, Labelle M YB. Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease. Brain Res 2004; 1003: 26–35
   PubMed Web of Science ®Google Scholar
• Kantarci K, Xu Y, Shiung MM, O'Brien PC, Cha RH, Smith GE, et al. Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord 2002; 14: 198–207
   PubMedGoogle Scholar
• Jessen F, Block W, Traber F, Keller E, Flacke S, Lamerichs R, et al. Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology 2001; 57: 930–2
   PubMed Web of Science ®Google Scholar
• Kantarci K, Reynolds G, Petersen RC, Boeve BF, Knopman DS, Edland SD, et al. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T. Am J Neuroradiol 2003; 24: 843–9
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C; American Psychiatric Association; 1994.
   Google Scholar
• Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984; 225: 1168–70
   PubMed Web of Science ®Google Scholar
• Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303–8
   PubMed Web of Science ®Google Scholar
• Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myoinositol with proton MR spectroscopy. Radiology 1993; 187: 433–37
   PubMed Web of Science ®Google Scholar
• Huang W, Alexander GE, Chang L, Shetty HU, Krasuski JS, Rapoport SI, et al. Brain metabolite concentration and dementia severity in Alzheimer's disease: a 1H MRS study. Neurology 2001; 57: 626–32
   PubMedGoogle Scholar
• Block W, Jessen F, Träber F, Flacke S, Manka C, Lamerichs R, et al. Regional N-acetylaspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with Alzheimer disease. Arch Neurol 2002; 59: 828–34
   Google Scholar
• Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Lim KO. In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. Arch General Psychiatry 1999; 56: 185–92
   PubMedGoogle Scholar
• Parnetti L, Tarducci R, Presciutti O, Lowenthal DT, Pippi M, Palumbo B, et al. Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging. Mech Ageing Dev 1997; 97: 9–14
   PubMed Web of Science ®Google Scholar
• Lazeyras F, Charles HC, Tupler LA, Erickson R, Boyko OB, Krishnan KR. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy. Psychiatry Res 1998; 82: 95–106
   PubMed Web of Science ®Google Scholar
• MacKay S, Ezekiel F, Di Sciafani V, Meyerhoff DJ, Gerson J, Norman D, et al. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and 1H MR spectroscopic imaging. Radiology 1996; 198: 537–45
   PubMed Web of Science ®Google Scholar
• Rose SE, de Zubicaray GI, Wang D, Galloway G, Chalk J, Eagle S, et al. A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. Magn Reson Imaging 1999; 17: 291–9
   PubMed Web of Science ®Google Scholar
• Zhu X, Schuff N, Kornak J, Soher B, Yaffe K, Kramer JH, et al. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging. Alzheimer Dis Assoc Disord 2006; 20: 77–85
   Google Scholar
• Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, et al. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 1313–22
   Google Scholar
• Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology 2001; 56: 592–8
   PubMed Web of Science ®Google Scholar
• Moats RA, Ernst T, Shonk TK, Ross BD. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 1994; 32: 110–5
   PubMed Web of Science ®Google Scholar
• Schuff N, Ezekiel F, Gamst A, Amend DL, Capizzano AA, Maudsley AA, et al. Region and tissue differences of metabolites in normally aged brain using 1H magnetic resonance spectroscopic imaging. Magn Reson Med 2001; 45: 899–907
   Google Scholar
• Catani M, Cherubini A, Howard R, Howard R, Tarducci R, Pelliccioli GP, et al. 1H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging. Neuroreport 2001; 12: 2315–7
   PubMed Web of Science ®Google Scholar
• Ackl N, Ising M, Schreiber YA, Atiya M, Sonntag A, Auer DP. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2005; 384: 23–8
   PubMed Web of Science ®Google Scholar
• Chantal S, Labelle M, Bouchard RW, Braun CM, Boulanger Y. Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease. Arch Neurol 2002; 59: 955–62
   PubMedGoogle Scholar
• Martinez-Bisbal MC, Arana E, Marti-Bonmati L, Mollá E, Celda B. Cognitive impairment: classification by 1H magnetic resonance spectroscopy. Eur J Neurol 2004; 11: 187–93
   Google Scholar
• Engelhardt E, Moreira DM, Laks J, Cavalcanti JL. Alzheimer's disease and proton magnetic resonance spectroscopy of limbic regions: a suggestion of a clinical-spectroscopic staging. Arq-Neuropsiquiatr 2005; 63: 195–200
   PubMed Web of Science ®Google Scholar